Suppr超能文献

变应性肉芽肿性血管炎的临床特征及预后因素

Clinical features and prognostic factors of Churg-Strauss syndrome.

作者信息

Kim Mi-Yeong, Sohn Kyoung-Hee, Song Woo-Jung, Park Heung-Woo, Cho Sang-Heon, Min Kyung-Up, Kang Hye-Ryun

机构信息

Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.

Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. ; Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Korea.

出版信息

Korean J Intern Med. 2014 Jan;29(1):85-95. doi: 10.3904/kjim.2014.29.1.85. Epub 2014 Jan 2.

Abstract

BACKGROUND/AIMS: Churg-Strauss syndrome (CSS) is a rare systemic necrotizing small-vessel vasculitis, with accompanying bronchial asthma, eosinophilia, and eosinophilic infiltration of various tissues. The purposes of our study were to characterize the clinical features of CSS and to identify factors associated with CSS prognosis in Koreans.

METHODS

Medical records were reviewed retrospectively for all physician-diagnosed CSS patients in the Seoul National University Hospital between January 1990 and March 2011.

RESULTS

Data from 52 CSS patients were analyzed. The respiratory tract was the most commonly involved organ (90.4%). Renal involvement was less frequent in antineutrophilic cytoplasmic antibody (ANCA)(-) patients than in ANCA(+) patients (p = 0.048). Clinical remission occurred in 95.3% of patients, but 16.3% of them relapsed. Patients who maintained remission for more than 6 months were relatively older (median, 51 years) at diagnosis (p = 0.004), had been diagnosed in earlier stages (p = 0.027), showed more frequent respiratory involvement (p = 0.024) and generalized symptoms (p = 0.039), and showed less frequent cutaneous involvement (p = 0.030) than those who did not achieve persistent (> 6 months) remission. Patients who achieved persistent remission also showed higher C-reactive protein (CRP) levels (p = 0.031) than those who did not.

CONCLUSIONS

ANCA(-) CSS patients showed less frequent renal involvement. Characteristics of good responders were older age, diagnosis at earlier stages, less cutaneous involvement, more respiratory involvement, high CRP values, and more generalized symptoms.

摘要

背景/目的:变应性肉芽肿性血管炎(CSS)是一种罕见的系统性坏死性小血管炎,伴有支气管哮喘、嗜酸性粒细胞增多以及各种组织的嗜酸性粒细胞浸润。我们研究的目的是描述韩国CSS患者的临床特征,并确定与CSS预后相关的因素。

方法

回顾性分析1990年1月至2011年3月期间首尔国立大学医院所有经医生诊断的CSS患者的病历。

结果

分析了52例CSS患者的数据。呼吸道是最常受累的器官(90.4%)。抗中性粒细胞胞浆抗体(ANCA)阴性患者的肾脏受累频率低于ANCA阳性患者(p = 0.048)。95.3%的患者实现了临床缓解,但其中16.3%复发。缓解持续超过6个月的患者在诊断时年龄相对较大(中位数为51岁)(p = 0.004),诊断时处于早期阶段(p = 0.027),呼吸道受累更频繁(p = 0.024),全身症状更常见(p = 0.039),皮肤受累频率低于未实现持续(>6个月)缓解的患者(p = 0.030)。实现持续缓解的患者的C反应蛋白(CRP)水平也高于未实现持续缓解的患者(p = 0.031)。

结论

ANCA阴性的CSS患者肾脏受累频率较低。缓解良好者的特征为年龄较大、早期诊断、皮肤受累较少、呼吸道受累较多、CRP值高以及全身症状较多。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3b0/3932399/3b65677119b2/kjim-29-85-g001.jpg

相似文献

1
Clinical features and prognostic factors of Churg-Strauss syndrome.
Korean J Intern Med. 2014 Jan;29(1):85-95. doi: 10.3904/kjim.2014.29.1.85. Epub 2014 Jan 2.
2
Churg-Strauss syndrome.
Autoimmun Rev. 2015 Apr;14(4):341-8. doi: 10.1016/j.autrev.2014.12.004. Epub 2014 Dec 11.
3
Churg-Strauss syndrome: 2005-2008 update.
Curr Rheumatol Rep. 2008 Dec;10(6):453-8. doi: 10.1007/s11926-008-0074-x.
4
[Churg-Strauss syndrome: outcome and long-term follow-up of 38 patients from a single Italian centre].
Reumatismo. 2009 Apr-Jun;61(2):118-24. doi: 10.4081/reumatismo.2009.118.
9
Churg-Strauss syndrome.
Semin Respir Crit Care Med. 2006 Apr;27(2):148-57. doi: 10.1055/s-2006-939518.

引用本文的文献

2
Intractable middle ear effusion in EGPA patients might cause permanent hearing loss: a case-control study.
Allergy Asthma Clin Immunol. 2022 Aug 6;18(1):68. doi: 10.1186/s13223-022-00706-x.
3
Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America.
ACR Open Rheumatol. 2021 Jun;3(6):404-412. doi: 10.1002/acr2.11263. Epub 2021 May 25.
5
Eosinophilic Granulomatosis with Polyangiitis: Experiences in Korean Patients.
Yonsei Med J. 2019 Aug;60(8):705-712. doi: 10.3349/ymj.2019.60.8.705.
6
Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Korea: A Narrative Review.
Yonsei Med J. 2019 Jan;60(1):10-21. doi: 10.3349/ymj.2019.60.1.10.
7
Cutaneous manifestations of Churg-Strauss syndrome: key to diagnosis.
An Bras Dermatol. 2017;92(5 Suppl 1):56-58. doi: 10.1590/abd1806-4841.20175522.
8
A 43-year-old patient presenting with marked eosinophilia and multisystem disease.
Breathe (Sheff). 2016 Sep;12(3):e77-e82. doi: 10.1183/20734735.009016.

本文引用的文献

1
Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment.
Semin Respir Crit Care Med. 2011 Jun;32(3):298-309. doi: 10.1055/s-0031-1279826. Epub 2011 Jun 14.
2
Cutting edge issues in the Churg-Strauss syndrome.
Clin Rev Allergy Immunol. 2013 Feb;44(1):39-50. doi: 10.1007/s12016-011-8266-y.
4
Clinical manifestations and treatment of Churg-Strauss syndrome.
Rheum Dis Clin North Am. 2010 Aug;36(3):527-43. doi: 10.1016/j.rdc.2010.05.003. Epub 2010 Jun 20.
6
A case of churg-strauss syndrome.
Ann Dermatol. 2009 May;21(2):213-6. doi: 10.5021/ad.2009.21.2.213. Epub 2009 May 31.
7
Mortality in systemic vasculitis: a systematic review.
Clin Exp Rheumatol. 2008 Sep-Oct;26(5 Suppl 51):S94-104.
8
Advances in the treatments of systemic vasculitides.
Clin Rev Allergy Immunol. 2008 Oct;35(1-2):72-8. doi: 10.1007/s12016-007-8068-4.
9
Churg-Strauss syndrome: the clinical features and long-term follow-up of 17 patients.
J Korean Med Sci. 2006 Apr;21(2):265-71. doi: 10.3346/jkms.2006.21.2.265.
10
Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome.
Ann Intern Med. 2005 Nov 1;143(9):632-8. doi: 10.7326/0003-4819-143-9-200511010-00006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验